Literature DB >> 7017918

Calcinosis in dermatomyositis treated with probenecid.

E Skuterud, O A Sydnes, T K Haavik.   

Abstract

Childhood dermatomyositis is frequently complicated by deposition of calcium salts in the soft tissues. This calcinosis represents a major problem, as severe disability may result. Various drugs have been tried to dissolve the calcinosis, but the results of these trials are disappointing. In this article we present a case report of a 9-year-old girl treated with probenecid. This treatment led to a dramatic decrease in subcutaneous and intermuscular calcinosis. The authors call for controlled studies of probenecid treatment in calcinosis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7017918     DOI: 10.3109/03009748109095279

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  3 in total

1.  Staphylococcal infections in childhood dermatomyositis--association with the development of calcinosis, raised IgE concentrations and granulocyte chemotactic defect.

Authors:  E C Moore; F Cohen; S D Douglas; V Gutta
Journal:  Ann Rheum Dis       Date:  1992-03       Impact factor: 19.103

Review 2.  Juvenile-onset clinically amyopathic dermatomyositis: an overview of recent progress in diagnosis and management.

Authors:  Hobart W Walling; Pedram Gerami; Richard D Sontheimer
Journal:  Paediatr Drugs       Date:  2010       Impact factor: 3.022

3.  Dramatic Improvement of Subcutaneous Calcinosis by Intermittent, High-Dose Etidronate plus Cimetidine in a Patient with Juvenile Dermatomyositis.

Authors:  Takayuki Wakabayashi; Noriko Sasaki; Naofumi Chinen; Yasuo Suzuki
Journal:  Case Rep Rheumatol       Date:  2015-11-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.